You are here

Our science / Clinical Trials / Find a Trial / NCT00668967

Bioequivalence Study Of Verapamil

Back to Search Print Save as PDF Bookmark Trial

NCT00668967

Last updated on February 20, 2019
Back to Search Print Save as PDF Bookmark Trial

FOR MORE INFORMATION
Study Location
Pfizer Investigational Site
New Haven, Connecticut, 06511 United States
See other locations
Contact
1-800-718-1021
[email protected]
Related Links
Eligibility criteria
Condition
The disease, disorder, syndrome, illness, or injury that is being studied.
Healthy Volunteers
Sex
Females and Males
Age
Pediatric Trials: 0-17 Years
Adult Trials: 18+ Years
18-55 years
Inclusion criteria
The factors, or reasons, that allow a person to participate in a clinical study.
Show details

- Healthy male and/or female subjects

- Mass Index (BMI) of approximately 18 to 30 kg/m2

Exclusion criteria
The factors, or reasons, that prevent a person from participating in a clinical study.
Show details

- Any condition possibly affecting drug absorption

- A positive urine drug screen

NCT00668967
Pfizer
Completed
Bioequivalence Study Of Verapamil

NEED INFO?

Questions about a trial? Call or email to reach a Pfizer Clinical Trial Contact Center

Pfizer Clinical Trials Contact Center

1-800-718-1021

[email protected]

call now

Try a new search

Search for Clinical Trials by condition, keyword or trial number. Share your location or enter your city or zip code to find studies near you.
Advanced Search

Based on your search, you may also be interested in

Healthy Volunteers
A Pharmacokinetic And QT Study Of CP-751,871 In Healthy Subjects
NCT00926263
All Genders
18+
Years
New Haven, Connecticut
Healthy Volunteers
Drug Interaction Study Between Raltegravir And UK-453,061
NCT00784420
All Genders
18+
Years
New Haven, Connecticut
Healthy Volunteers
Multiple Ascending Dose and DDI Study
NCT03031119
All Genders
18+
Years
Brussels,
Healthy Volunteers
Triazolam Trial In Healthy Subjects To Compare Bioavailability Between Formulations Of Triazolam To Determine Their Bioequivalence In Terms Of Rate And Magnitude Of Absorption
NCT01017926
All Genders

FOR MORE INFORMATION

Contact a representative by phone, email, or visiting the study website. Please see the references below:

BY PHONE

Pfizer Clinical Trials Contact Center

1-800-718-1021

BY EMAIL

Contact

[email protected]

Call Now